Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to Michael Graner

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Graner, Michael

Item TypeName
Academic Article Tumor-derived multiple chaperone enrichment by free-solution isoelectric focusing yields potent antitumor vaccines.
Academic Article Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells.
Academic Article Induction of BCR-ABL-specific immunity following vaccination with chaperone-rich cell lysates derived from BCR-ABL+ tumor cells.
Academic Article Imatinib mesylate effectively combines with chaperone-rich cell lysate-loaded dendritic cells to treat bcr-abl+ murine leukemia.
Academic Article Chaperone-rich cell lysates, immune activation and tumor vaccination.
Academic Article Peritransplantation vaccination with chaperone-rich cell lysate induces antileukemia immunity.
Academic Article Chaperone-rich cell lysate embedded with BCR-ABL peptide demonstrates enhanced anti-tumor activity against a murine BCR-ABL positive leukemia.
Academic Article Immunoprotective activities of multiple chaperone proteins isolated from murine B-cell leukemia/lymphoma.
Academic Article Vesiculated alpha-tocopheryl succinate enhances the anti-tumor effect of dendritic cell vaccines.
Academic Article Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate antitumor immunity.
Academic Article Tumor-derived chaperone-rich cell lysates are effective therapeutic vaccines against a variety of cancers.
Academic Article Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma.
Academic Article Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens.
Concept Cancer Vaccines
Academic Article The 'peptidome' of tumour-derived chaperone-rich cell lysate anti-cancer vaccines reveals potential tumour antigens that stimulate tumour immunity.
Academic Article Prolonged remission of advanced bronchoalveolar adenocarcinoma in a dog treated with autologous, tumour-derived chaperone-rich cell lysate (CRCL) vaccine.
Academic Article Proteomic analyses of different human tumour-derived chaperone-rich cell lysate (CRCL) anti-cancer vaccines reveal antigen content and strong similarities amongst the vaccines along with a basis for CRCL's unique structure: CRCL vaccine proteome leads to unique structure.
Academic Article Endoplasmic reticulum chaperones and their roles in the immunogenicity of cancer vaccines.
Academic Article Extracellular vesicles in cancer immune responses: roles of purinergic receptors.

Search Criteria
  • Cancer Vaccines

Copyright © 2021 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)